![Soren Nielsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Soren Nielsen
Chief Executive Officer at Reponex Pharmaceuticals A/S
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Troels Peter Troelsen | M | 78 |
AKI Therapeutics ApS
![]() AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.
Reponex Pharmaceuticals A/S
![]() Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | - |
Christian Vinding Thomsen | M | - |
AKI Therapeutics ApS
![]() AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016.
Reponex Pharmaceuticals A/S
![]() Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | 3 years |
Peter Morch Eriksen | M | 64 |
Reponex Pharmaceuticals A/S
![]() Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | - |
Lars Otto Uttenthal | M | 79 |
AKI Therapeutics ApS
![]() AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016. | - |
Troels Ring | M | - |
AKI Therapeutics ApS
![]() AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016. | - |
Charlotte Pahl | F | - |
Reponex Pharmaceuticals A/S
![]() Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Denmark | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Soren Nielsen
- Personal Network